Zobrazeno 1 - 10
of 15
pro vyhledávání: '"D. R. Gretch"'
Autor:
Merlyn H. Sayers, D. R. Gretch
Publikováno v:
Transfusion. 33:809-813
The purpose of this study was to compare the results of supplementary testing of volunteer whole blood donors who had been screened by the first hepatitis C virus antibody assay licensed in the United States with results from donors screened by a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e84eb90299ba09dd74b48d0db078060
https://doi.org/10.1046/j.1537-2995.1993.331094054616.x
https://doi.org/10.1046/j.1537-2995.1993.331094054616.x
Autor:
K R, Jerome, D R, Gretch
Publikováno v:
Minerva gastroenterologica e dietologica. 50(1)
Hepatitis C virus (HCV) infection is a major and growing health problem worldwide. Laboratory testing plays an important role in the response to the HCV epidemic. Serologic tests for antibody to HCV are useful for screening purposes. The mainstays of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa8b844d393f170227a04b11d555516b
https://pubmed.ncbi.nlm.nih.gov/15719002
https://pubmed.ncbi.nlm.nih.gov/15719002
Publikováno v:
Clinical chemistry. 46(12)
To review information on performance characteristics for tests that are commonly used to identify acute and chronic hepatic injury.A MEDLINE search was performed for key words related to hepatic tests, including quality specifications, aminotransfera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da1539173c8ac73a10d5f8c11d500914
https://pubmed.ncbi.nlm.nih.gov/11375313
https://pubmed.ncbi.nlm.nih.gov/11375313
Autor:
J M, Pawlotsky, D R, Gretch
Publikováno v:
Antiviral therapy. 3(Suppl 3)
The treatment of chronic hepatitis C is aimed at eliminating viral replication in order to prevent further evolution towards cirrhosis and hepatocellular carcinoma. Virological parameters include hepatitis C virus (HCV) genotype, qualitative viraemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1d4489e5d1174c94a067de5ec43c9f6
https://pubmed.ncbi.nlm.nih.gov/10726055
https://pubmed.ncbi.nlm.nih.gov/10726055
Publikováno v:
Transplantation. 65(9)
The majority of patients infected with hepatitis C virus (HCV) undergoing liver transplantation develop evidence of histologic recurrence, and multiple mechanisms are likely poised to affect long-term allograft injury. The purpose of this analysis wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5913d3695b7623620207b10d8714063d
https://pubmed.ncbi.nlm.nih.gov/9603164
https://pubmed.ncbi.nlm.nih.gov/9603164
Publikováno v:
Journal of medical virology. 53(2)
Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [Enomoto et al. (1995): Journal of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::69b6f1e9603e29d62d2e7798ad456eb2
https://pubmed.ncbi.nlm.nih.gov/9334922
https://pubmed.ncbi.nlm.nih.gov/9334922
Autor:
H R, Rosen, S, Chou, C L, Corless, D R, Gretch, K D, Flora, A, Boudousquie, S L, Orloff, J M, Rabkin, K G, Benner
Publikováno v:
Transplantation. 64(5)
Despite recent advances in diagnosis and treatment, cytomegalovirus (CMV) infection continues to be a common cause of morbidity in liver transplant (LT) recipients. Because CMV infection suppresses cell-mediated immunity, which seems to be important
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::427c3dcb2ead1990446657109547f369
https://pubmed.ncbi.nlm.nih.gov/9311709
https://pubmed.ncbi.nlm.nih.gov/9311709
Autor:
Thelma E. Wiley, Nancy P. Lam, Thomas J. Layden, D R Gretch, Alan S. Perelson, Avidan U. Neumann
Publikováno v:
Hepatology (Baltimore, Md.). 26(1)
To determine if the clearance of hepatitis C genotype 1 virus (HCV) is dependent on the dose of interferon alfa-2b (IFN-alpha2b), the acute clearance of HCV after a single dose of either 3, 5, or 10 mIU of IFN-alpha was compared in patients with chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95dd5bdd013dcd176cdea67c4604ca0b
https://pubmed.ncbi.nlm.nih.gov/9398023
https://pubmed.ncbi.nlm.nih.gov/9398023
Publikováno v:
The Journal of rheumatology. 23(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d75310cb6a0a9fe784bd4065ee0340a4
https://pubmed.ncbi.nlm.nih.gov/8782121
https://pubmed.ncbi.nlm.nih.gov/8782121
Publikováno v:
Advances in experimental medicine and biology. 394
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e39e3858d83f394bd02f94ae65dc5f6f
https://pubmed.ncbi.nlm.nih.gov/8815687
https://pubmed.ncbi.nlm.nih.gov/8815687